Funding Briefs

Young biomedical scientists will lose a major source of postdoctoral training funds as a result of the decision by the Lucille P. Markey Charitable Trust to terminate its Markey Scholars in Biomedical Science program. The trust, created by the heir to the Calumet Farm horseracing fortune, was established in 1982 with the stipulation that all its funds be distributed by 1997. The trustees decided that its seventh round of scholars, announced in February, would be its last. Since the Scholar Aw

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Young biomedical scientists will lose a major source of postdoctoral training funds as a result of the decision by the Lucille P. Markey Charitable Trust to terminate its Markey Scholars in Biomedical Science program. The trust, created by the heir to the Calumet Farm horseracing fortune, was established in 1982 with the stipulation that all its funds be distributed by 1997. The trustees decided that its seventh round of scholars, announced in February, would be its last.

Since the Scholar Awards program was established in 1984, the trust has committed more than $62 million in support of 115 scientists from 33 academic institutions.

The Program on Science and International Security of the American Association for the Advancement of Science offers its second annual Hilliard Roderick Prize for Excellence in Science, Arms Control, and International Security. The prize was established by Roderick's widow, Ulla Magnusson. Roderick, a physicist, worked at the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies